Key Drivers
- Operating Collapse
- Liquidity Cushion
- Rising Leverage
AIAI Summary
TRLV is a catalyst-dependent trade: strong 60% gross margins and liquidity could drive major cash-flow and balance-sheet upside if Schedule III/280E relief materializes, but investors should wait for evidence that regulatory benefits can offset volatile losses and rising leverage.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Operating Collapse
- •Liquidity Cushion
- •Rising Leverage
TRLV's strong 2025 operations and liquidity have been overshadowed by a severe 2026 earnings collapse, weakening cash flow, rising leverage, and an uninformative negative P/E—warranting caution.
Price Behavior
Key Price Behavior Insights:
- •Recovery weakening
- •$11 support
- •$11.80 breakout
TRLV is up about 8% over the last month but has weakened after an 11% pullback from $12.43, with a move above $11.80 bullish and a break below $11.00 risking a decline toward $10.25.
Sharp 11% decline from $12.43 to $11.07 in 10 days
Sentiment & News
Key News Insights:
- •Schedule III upside
- •Southeast expansion
- •Tax reversal potential
Trulieve gains potential upside from rescheduling-driven tax relief and strategic Southeast expansion, though regulatory uncertainty remains a key risk.
The developments are broadly positive for Trulieve's growth and margins, but policy volatility could temper investor enthusiasm
Similar Companies in Healthcare
Other companies in the same sector with AI ratings